326 participants
Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-11-19
- Start Date:
- 2013-03-14
- Completion:
- 2017-09-14
Conditions
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Diffuse Large B-cell Lymphoma
- Non-FL Indolent Non-Hodgkin's Lymphoma
- Follicular Lymphoma
Interventions
- DRUG